LABATE, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 3.189
AS - Asia 1.397
EU - Europa 1.292
SA - Sud America 61
OC - Oceania 18
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 5.974
Nazione #
US - Stati Uniti d'America 3.090
SG - Singapore 1.007
IT - Italia 562
CN - Cina 266
SE - Svezia 227
GB - Regno Unito 164
CA - Canada 92
EE - Estonia 91
DE - Germania 59
RU - Federazione Russa 49
HK - Hong Kong 46
BR - Brasile 38
IN - India 31
RO - Romania 28
FI - Finlandia 25
NL - Olanda 22
AU - Australia 17
FR - Francia 13
JP - Giappone 13
CO - Colombia 10
ZA - Sudafrica 8
MX - Messico 7
UA - Ucraina 7
CH - Svizzera 6
CL - Cile 6
CZ - Repubblica Ceca 5
IR - Iran 5
TR - Turchia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
ES - Italia 4
PL - Polonia 4
BE - Belgio 3
BG - Bulgaria 3
GR - Grecia 3
IE - Irlanda 3
IQ - Iraq 3
KR - Corea 3
MK - Macedonia 3
PK - Pakistan 3
SA - Arabia Saudita 3
VE - Venezuela 3
BD - Bangladesh 2
EU - Europa 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.974
Città #
Chandler 660
Singapore 369
Santa Clara 271
Princeton 221
Lawrence 220
Milan 220
London 142
Chicago 132
Wilmington 115
Des Moines 80
Ottawa 75
Ashburn 60
Boardman 46
Hong Kong 42
Catanzaro 40
Shanghai 37
Los Angeles 27
The Dalles 26
Guangzhou 25
Rome 22
Munich 20
Redwood City 19
Norwalk 16
Pune 16
Redmond 16
Helsinki 15
Beijing 13
Council Bluffs 13
Naples 13
Seattle 10
Shenzhen 10
Turku 10
Amsterdam 9
Timisoara 9
Augusta 8
Falls Church 8
Horia 8
St Petersburg 8
Casalnuovo Di Napoli 7
Florence 7
Melbourne 7
Toronto 7
Atlanta 6
Brooklyn 6
Buffalo 6
Hefei 6
New York 6
San Nicola Manfredi 6
São Paulo 6
Bethesda 5
Castiglion Fibocchi 5
Hanover 5
Mexico City 5
Montreal 5
Paris 5
Rui'an 5
Taranto 5
Tokyo 5
Valmadrera 5
Wuhan 5
Wuxi 5
Xuzhou 5
Assago 4
Aversa 4
Berlin 4
Bologna 4
Carrara 4
Catania 4
Cetraro 4
Falerna 4
Gatchina 4
Genoa 4
Moscow 4
Reggio Calabria 4
Rimini 4
San Francisco 4
San Jose 4
Treviso 4
Washington 4
Wuhu 4
Xi'an 4
Ann Arbor 3
Cagliari 3
Chennai 3
Clearwater 3
Crotone 3
Danvers 3
Dublin 3
Durban 3
Guidonia Montecelio 3
Jiaxing 3
Johannesburg 3
Las Vegas 3
Lexington 3
Locri 3
Missaglia 3
Novara 3
Olomouc 3
Perth 3
Potenza 3
Totale 3.319
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 139
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 115
Genetics of reflex seizures and epilepsies in humans and animals 110
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 97
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 70
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study 67
Neocortical thinning in “benign” mesial temporal lobe epilepsy 59
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 58
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 57
Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. 47
Long-term outcome of mild mesial temporal lobe epilepsy 44
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 40
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 40
Age at onset predicts good seizure outcome in sporadic non-lesional and mesial temporal sclerosis based temporal lobe epilepsy 39
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 39
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 39
Neuropsychological profile of mild temporal lobe epilepsy 38
A puzzling case without solution: isolated late-onset epileptic seizure 38
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 37
Structural brain abnormalities in the common epilepsies assessed in 3,876 individuals worldwide 37
Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy. 36
Teaching NeuroImages: Pseudohypertrophic cerebral cortex in end-stage Creutzfeldt-Jakob disease 36
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 36
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 36
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy 35
Why should we change the term psychogenic nonepileptic seizures (PNES)? 35
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 35
Diagnostic Biomarkers of Epilepsy 35
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 35
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 35
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 35
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 34
Psychopathological constellation in Psychogenic Non-Epileptic Seizures 34
Gerstmann-Straussler-Scheinker disease with PRNP P102L heterozygous mutation presenting as progressive myoclonus epilepsy. 33
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 33
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 33
Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness 32
Reversible symmetrical external capsule hyperintensity as an early finding of autoimmune encephalitis. 32
A new Italian instrument for the assessment of irritability in patients with epilepsy. 32
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 32
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 32
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 32
A novel mutation in the notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and MRI spectroscopic analyses 32
Association between the M129V variant allele of PRNP gene and mild temporal lobe epilepsy in women 31
Mild Lafora disease: Clinical, neurophysiologic, and genetic findings. 31
Modeling epileptogenic lesions and mapping networks - Imaging genetics for benign mesial temporal lobe epilepsy 31
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features. 31
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 31
White Matter Abnormalities Differentiate Severe from Benign Temporal Lobe Epilepsy. 30
Functional activity changes in memory and emotional systems of healthy subjects with déjà vu. 30
Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study 30
Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report 30
Prodynorphin gene promoter polymorphism and temporal lobe epilepsy 30
Brainstem Posterior Reversible Encephalopathy Syndrome in an Asymptomatic Patient. 30
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 30
Cerebral venous thrombosis and isolated intracrania hypertension without papilledema in CDH 29
Permutation entropy of scalp EEG: A tool to investigate epilepsies: Suggestions from absence epilepsies. 29
Brand-to-Generic Levetiracetam Switching: a four-years prospective observational real-life study 29
The meaning of anxiety in patients with PNES. 29
Advanced MRI Morphologic Study Shows No Atrophy in Healthy Individuals with Hippocampal Hyperintensity 29
Tremor pattern differentiates drug-induced resting tremor from Parkinson disease. 29
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures 29
An SNP site in pri-miR-124, a brain expressed miRNA gene, no contribution to mesial temporal lobe epilepsy in an Italian sample. 29
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 28
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 28
Value of clinical features to differentiate refractory epilepsy from mimics: a prospective longitudinal cohort study. 28
Detection of hippocampal atrophy in patients with temporal lobe epilepsy: a 3-Tesla MRI shape. 28
Spontaneous obliteration of MRI-silent cerebral angiomatosis revealed by CT angiography in a patient with Sturge-Weber syndrome 28
The parkin gene is not involved in late-onset Parkinson’s disease 28
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 28
Profile of brivaracetam and its potential in the treatment of epilepsy 28
Value of multimodal imaging approach to diagnosis of neurosarcoidosis 28
The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study 27
Hepatonecrosis and cholangitis related to long-term phenobarbital therapy: An autopsy report of two patients 27
Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectives 27
Why should we change the term psychogenic nonepileptic seizures? 27
Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals 27
Blocking out the real diagnosis 27
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study 27
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: a open label study 27
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study 27
Familial mesial temporal lobe epilepsy (FMTLE): a clinical and genetic study of 15 Italian families 26
Familial mesial temporal lobe epilepsies: clinical and genetic features 26
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy. Manna I, Gambardella A, Labate A, Mumoli L, Ferlazzo E, Pucci F, Aguglia U, Quattrone A. Seizure. 2015 Jan;24:124-6. 26
Impact of catechol-O-methyltransferase Val108/158 Met genotype on hippocampal and prefrontal gray matter volume 26
Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy 26
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 26
Corrigendum to “Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study” [Epilepsy Behav 74 (2017) Pages 69–72] 26
Late drug-resistance in mild MTLE: Can it be influenced by preexisting white matter alterations? 26
Autosomal dominant lateral temporal epilepsy (ADLTE): absence of chromosomal rearrangements in LGI1 gene. 26
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study 26
The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study 26
PCDH19 mutations in female patients from Southern Italy. 25
Hypersomnia hiding a bipolar disorder 25
Further evidence of genetic heterogeneity in families with autosomal dominant nocturnal frontal lobe epilepsy 25
Usefulness of rectal biopsy for the diagnosis of Kufs disease: a controlled study and review of the literature. 25
Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH 25
Preoperative non invasive electrophysiological evaluation and neuroradiological examination in epilepsy surgery 25
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 25
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis 25
Totale 3.568
Categoria #
all - tutte 86.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020108 0 0 0 0 0 0 0 0 0 0 30 78
2020/2021240 10 5 5 31 26 14 7 25 72 27 13 5
2021/2022667 14 1 0 173 66 13 13 133 81 63 105 5
2022/20231.786 448 94 44 202 207 175 4 110 271 102 107 22
2023/2024836 167 120 85 51 56 191 18 31 9 17 26 65
2024/20252.498 366 218 169 146 212 410 129 94 354 222 178 0
Totale 6.199